Weight loss medications are ruining Thanksgiving by eliminating sugar and butter too
Thanksgiving Shifts as Families Adapt to Health Trends Thanksgiving is shaping up to be quite different this year for many families, especially those dealing with nutrition and health changes. For new moms, like Jennifer Stojkovic, whose son Roman was born in September, the holiday presents both a craving for comfort food and a challenge. With […]
Managing holiday meals while using GLP-1 weight-loss medications
Impact of GLP-1 Weight Loss Medications on Social Interactions GLP-1 medications can aid in weight loss and support blood sugar control, but they also have the potential to alter social interactions significantly. As the holiday season draws near, those taking obesity medications may struggle with family meals or larger gatherings. This is largely due to […]
Study in the UK Will Allow Children as Young as Ten to Receive Puberty-Blocking Medications
Clinical Trials for Transgender Drugs in Children Underway in the UK In the UK, children aged 10 and older are set to participate in clinical trials involving transgender medications, despite the government’s prohibition on the public use of puberty blockers. Last year, a prominent study led by pediatrician Dr. Hilary Cass suggested that the practice […]
GLP-1 medications might allow colon cancer patients to have a longer life, research suggests
Study Links GLP-1 Drugs to Longer Lives for Colon Cancer Patients A recent study indicates that colon cancer patients could experience longer lifespans if they use GLP-1 medications, including Ozempic and Wegovy. Researchers from the University of California, San Diego examined over 6,800 patients who were prescribed these common diabetes and weight-loss drugs. The results […]
What is the price of well-known obesity medications?
President Donald Trump announced a new agreement on Thursday that aims to make weight-loss drugs like Wegovy and Zepbound more affordable for Americans. This deal with drug manufacturers Novo Nordisk and Eli Lilly could reduce the price of GLP-1 medications to as low as $149 a month. Currently, these popular injections start at around $350 […]
Musk’s $1 trillion compensation, a reduction for obesity medications, Target’s store challenges, and more in Morning Squawk.
Here’s a snapshot of key developments that might interest investors as they kick off their trading day. 1. A $1 trillion compensation plan The world’s wealthiest individuals are poised to increase their fortunes. Yesterday, shareholders backed Elon Musk’s almost $1 trillion compensation package, with around 75% supporting it despite pushback from prominent proxy advisors. This […]
Trump reaches significant agreement with pharmaceutical companies Lilly and Novo regarding obesity medications and Medicare.
Addressing America’s Obesity Crisis Robert F. Kennedy Jr., the Secretary of Health and Human Services, is currently focused on pinpointing the underlying reasons behind the obesity epidemic in the United States. At the same time, the Trump administration aims to ensure affordable access to medications for diabetes and weight loss, particularly targeting glucagon-like peptide-1 receptor […]
Trump Reveals $250 Weight Loss Medications in New ‘TrumpRx’ Agreement
Trump Announces Discounts for Weight Loss Drugs President Donald Trump recently announced significant reductions in prices for GLP-1 weight loss medications during an Oval Office briefing. Collaborating with pharmaceutical companies Eli Lilly and Novo Nordisk, Trump revealed that Lilly’s Zepbound and Novo Nordisk’s Wegovy will soon be available at lower prices through a new direct-to-consumer […]
Trump plans to reveal reduced prices for weight-loss medications and broader Medicare eligibility.
Trump’s Announcement on Drug Price Reductions Later today, President Trump is set to reveal that two prominent pharmaceutical companies will be cutting the prices of GLP-1 medications, which are often used for diabetes treatment and weight management. Additionally, the government plans to broaden eligibility for these drugs under Medicare. Novo Nordisk, based in Denmark, produces […]
Brooks Nader acknowledges reliance on GLP-1 drugs, describes weight-loss medications as ‘a support’
Brooks Nader Addresses Weight Loss Drug Addiction Model Brooks Nader recently opened up about her ongoing struggle with addiction to weight loss drugs, despite her sisters’ intervention, which revealed a basket full of needles in her possession. During an episode of her reality show, “Love Thy Nader,” viewers saw Nader’s sisters confront her after finding […]